11:08:27Philippines

Standard BioTools Inc. (LAB)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
85,331,000 -6.2%
Net income
-74,896,000
Gross profit
42,543,000
Operating income
-110,249,000
Earnings per share
-0.20
R&D expense
25,987,000

Growth and profitability

Gross margin
49.86
Operating margin
-129.20
Net margin
-87.77
Return on equity
-17.65
Return on assets
-13.19
Free cash flow margin
-96.85

Balance sheet

Total assets
567,754,000
Total liabilities
143,463,000
Shareholders' equity
424,291,000
Cash and equivalents
120,863,000
Current ratio
4.19

Cash flow and ratios

Operating cash flow
-74,343,000
Free cash flow
-82,646,000

Shareholder returns

Share buybacks
0
Shares outstanding
394,790,441
Book value per share
1.07
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Boston, MA
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Standard BioTools Inc. trades on NASDAQ under the ticker symbol LAB. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis